On the public citation graph

Potential COVID-19 papain-like protease PL pro inhibitors: repurposing FDA-approved drugs

0 signed · 94 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/minf.202000028openalex-snapshot
Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
inferredcites →https://doi.org/10.1007/978-3-540-79086-0_4openalex-snapshot
Viral Protease Inhibitors
inferredcites →https://doi.org/10.1016/j.antiviral.2014.06.011openalex-snapshot
Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features
inferredcites →https://doi.org/10.1016/j.antiviral.2014.12.015openalex-snapshot
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
inferredcites →https://doi.org/10.1016/j.antiviral.2015.01.011openalex-snapshot
Protease inhibitors targeting coronavirus and filovirus entry
inferredcites →https://doi.org/10.1016/j.antiviral.2016.10.005openalex-snapshot
Bioinformatics and functional analyses of coronavirus nonstructural proteins involved in the formation of replicative organelles
inferredcites →https://doi.org/10.1016/j.antiviral.2017.11.001openalex-snapshot
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
inferredcites →https://doi.org/10.1016/j.apsb.2020.02.008openalex-snapshot
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.ijid.2020.02.018openalex-snapshot
Discovery and development of safe-in-man broad-spectrum antiviral agents
inferredcites →https://doi.org/10.1016/j.jgg.2020.02.001openalex-snapshot
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
inferredcites →https://doi.org/10.1016/j.lfs.2020.117627openalex-snapshot
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
inferredcites →https://doi.org/10.1021/cb500917mopenalex-snapshot
Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
inferredcites →https://doi.org/10.1021/jm200870nopenalex-snapshot
Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
inferredcites →https://doi.org/10.1038/s41422-020-0356-zopenalex-snapshot
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
inferredcites →https://doi.org/10.1038/s41467-020-18096-2openalex-snapshot
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
inferredcites →https://doi.org/10.1073/pnas.0505577102openalex-snapshot
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
inferredcites →https://doi.org/10.1073/pnas.0805240105openalex-snapshot
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
inferredcites →https://doi.org/10.1074/jbc.m704870200openalex-snapshot
Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
inferredcites →https://doi.org/10.1080/07391102.2020.1782768openalex-snapshot
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CL pro
inferredcites →https://doi.org/10.1088/1478-3975/abcb66openalex-snapshot
Potential SARS-CoV-2 protease M pro inhibitors: repurposing FDA-approved drugs
inferredcites →https://doi.org/10.1111/j.1747-0285.2007.00475.xopenalex-snapshot
In Silico Prediction of SARS Protease Inhibitors by Virtual High Throughput Screening
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1128/aac.03036-14openalex-snapshot
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1128/jvi.78.24.13600-13612.2004openalex-snapshot
Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity
inferredcites →https://doi.org/10.1145/2616498.2616540openalex-snapshot
Gateways to Discovery
inferredcites →https://doi.org/10.26434/chemrxiv.11860011openalex-snapshot
Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs
inferredcites →https://doi.org/10.26434/chemrxiv.11860011.v2openalex-snapshot
Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs
inferredcites →https://doi.org/10.3201/eid1004.030458openalex-snapshot
Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
inferredcites →https://doi.org/10.4084/mjhid.2020.031openalex-snapshot
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection
inferredcites →https://doi.org/10.7717/peerj.9965openalex-snapshot
Potential COVID-19 papain-like protease PL pro inhibitors: repurposing FDA-approved drugs

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/cmdc.202100079openalex-snapshot
Science's Response to CoVID‐19
inferred← citeshttps://doi.org/10.1002/slct.202303543openalex-snapshot
Molecular Docking Studies of Boron‐Containing Compounds as Dual Inhibitors of SARS‐Cov‐2 Spike Receptor Binding Domain/ACE2 Complex and Main Protease and ADMET Investigations
inferred← citeshttps://doi.org/10.1007/s00210-021-02091-5openalex-snapshot
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
inferred← citeshttps://doi.org/10.1007/s11696-025-03968-yopenalex-snapshot
Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation
inferred← citeshttps://doi.org/10.1007/s12033-024-01326-zopenalex-snapshot
Identification of Novel Drug Molecules Against NS3-Like Helicase Enzyme of Alongshan Virus
inferred← citeshttps://doi.org/10.1007/s12640-022-00542-2openalex-snapshot
A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease
inferred← citeshttps://doi.org/10.1016/b978-0-323-89837-9.00014-0openalex-snapshot
Biotechnology strategies for the development of novel therapeutics and vaccines against the novel COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.06.016openalex-snapshot
Recent advances in developing small-molecule inhibitors against SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.berh.2020.101657openalex-snapshot
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
inferred← citeshttps://doi.org/10.1016/j.bpc.2022.106824openalex-snapshot
The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects
inferred← citeshttps://doi.org/10.1016/j.cellsig.2022.110559openalex-snapshot
COVID-19 signalome: Potential therapeutic interventions
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104295openalex-snapshot
Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.106290openalex-snapshot
Identification of molecular mechanisms underlying the therapeutic effects of Celosia Cristata on immunoglobulin nephropathy
inferred← citeshttps://doi.org/10.1016/j.crphar.2021.100072openalex-snapshot
Strategies for drug repurposing against coronavirus targets
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.07.026openalex-snapshot
Advances in the computational landscape for repurposed drugs against COVID-19
inferred← citeshttps://doi.org/10.1016/j.ejmech.2026.118698openalex-snapshot
Integration of computational and experimental techniques for the discovery of PLpro covalent inhibitors. When large virtual screening and rational design meet
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174082openalex-snapshot
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases
inferred← citeshttps://doi.org/10.1016/j.molstruc.2025.141730openalex-snapshot
Review of the crystallized structures of the SARS-CoV-2 papain-like protease
inferred← citeshttps://doi.org/10.1016/j.sjbs.2021.12.018openalex-snapshot
Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
inferred← citeshttps://doi.org/10.1016/j.virol.2024.110239openalex-snapshot
Evolution of drug resistance against antiviral agents that target cellular factors
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c01652openalex-snapshot
Network-Driven Methods Using Gene Expression Signatures to Find Therapeutic Targets in Breast Cancer Validated via Molecular Dynamics Studies
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01307openalex-snapshot
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
inferred← citeshttps://doi.org/10.1021/acschemneuro.1c00350openalex-snapshot
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations
inferred← citeshttps://doi.org/10.1038/s41598-022-13267-1openalex-snapshot
Discovery of Rift Valley fever virus natural pan-inhibitors by targeting its multiple key proteins through computational approaches
inferred← citeshttps://doi.org/10.1042/bsr20202616openalex-snapshot
Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates
inferred← citeshttps://doi.org/10.1080/07391102.2021.1944909openalex-snapshot
In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
inferred← citeshttps://doi.org/10.1080/07391102.2023.2198017openalex-snapshot
Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer
inferred← citeshttps://doi.org/10.1080/07391102.2023.2214209openalex-snapshot
Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics
inferred← citeshttps://doi.org/10.1080/07391102.2023.2263588openalex-snapshot
Structure-based virtual screening of natural compounds as inhibitors of HCV using molecular docking and molecular dynamics simulation studies
inferred← citeshttps://doi.org/10.1080/14787210.2021.1851195openalex-snapshot
Drug repurposing: new strategies for addressing COVID-19 outbreak
inferred← citeshttps://doi.org/10.1093/bib/bbab490openalex-snapshot
Network analytics for drug repurposing in COVID-19
inferred← citeshttps://doi.org/10.1093/pcmedi/pbab001openalex-snapshot
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
inferred← citeshttps://doi.org/10.1109/cibcb49929.2021.9562855openalex-snapshot
Discovering Missing Edges in Drug-Protein Networks: Repurposing Drugs for SARS-CoV-2
inferred← citeshttps://doi.org/10.1111/sji.13044openalex-snapshot
Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19
inferred← citeshttps://doi.org/10.1155/2022/2044282openalex-snapshot
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies
inferred← citeshttps://doi.org/10.1186/s12859-023-05479-7openalex-snapshot
DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing
inferred← citeshttps://doi.org/10.1186/s13321-021-00553-9openalex-snapshot
Using informative features in machine learning based method for COVID-19 drug repurposing
inferred← citeshttps://doi.org/10.1248/cpb.c23-00622openalex-snapshot
In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease
inferred← citeshttps://doi.org/10.14218/jerp.2021.00050openalex-snapshot
Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs
inferred← citeshttps://doi.org/10.2174/1570163819666221010115118openalex-snapshot
In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs at SARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro)
inferred← citeshttps://doi.org/10.22159/ijap.2022v14i1.42311openalex-snapshot
LONG-TERM IMMUNOLOGICAL CONSEQUENCES OF COVID-19 ON HEALTH
inferred← citeshttps://doi.org/10.2217/fmb-2021-0019openalex-snapshot
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
inferred← citeshttps://doi.org/10.26434/chemrxiv-2023-r0v7topenalex-snapshot
Integration of Computational and Experimental Techniques for the Discovery of SARS-CoV-2 PLpro Covalent Inhibitors
inferred← citeshttps://doi.org/10.2991/dsahmj.k.210921.001openalex-snapshot
Virtual Screening and Inhibition of Middle East Respiratory Syndrome Coronavirus Replication by Targeting Papain-like Protease
inferred← citeshttps://doi.org/10.31083/j.fbl2704113openalex-snapshot
Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning
inferred← citeshttps://doi.org/10.3389/fbinf.2022.869375openalex-snapshot
A Molecular Docking Study of Human STEAP2 for the Discovery of New Potential Anti-Prostate Cancer Chemotherapeutic Candidates
inferred← citeshttps://doi.org/10.3389/fchem.2022.822785openalex-snapshot
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone
inferred← citeshttps://doi.org/10.3389/fmed.2021.752095openalex-snapshot
Investigating Fungi-Derived Bioactive Molecules as Inhibitor of the SARS Coronavirus Papain Like Protease: Computational Based Study
inferred← citeshttps://doi.org/10.3390/molecules26030674openalex-snapshot
Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
inferred← citeshttps://doi.org/10.3390/molecules27030683openalex-snapshot
DrugDevCovid19: An Atlas of Anti-COVID-19 Compounds Derived by Computer-Aided Drug Design
inferred← citeshttps://doi.org/10.3390/ph15060659openalex-snapshot
Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors
inferred← citeshttps://doi.org/10.52547/hsm.1.2.89openalex-snapshot
Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.1/reviews/1openalex-snapshot
Peer Review #1 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.1/reviews/2openalex-snapshot
Peer Review #2 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.1/reviews/3openalex-snapshot
Peer Review #3 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.1)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.2/reviews/2openalex-snapshot
Peer Review #2 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.2)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.2/reviews/3openalex-snapshot
Peer Review #3 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.2)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.3/reviews/2openalex-snapshot
Peer Review #2 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.3)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.3/reviews/3openalex-snapshot
Peer Review #3 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.3)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.4/reviews/2openalex-snapshot
Peer Review #2 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.4)"
inferred← citeshttps://doi.org/10.7287/peerj.11590v0.5/reviews/2openalex-snapshot
Peer Review #2 of "The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study (v0.5)"
inferred← citeshttps://doi.org/10.7717/peerj.11590openalex-snapshot
The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study
showing the first 62 of 63 · page through all 63
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.